ZA988674B - 21-Hydroy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids - Google Patents

21-Hydroy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids

Info

Publication number
ZA988674B
ZA988674B ZA988674A ZA988674A ZA988674B ZA 988674 B ZA988674 B ZA 988674B ZA 988674 A ZA988674 A ZA 988674A ZA 988674 A ZA988674 A ZA 988674A ZA 988674 B ZA988674 B ZA 988674B
Authority
ZA
South Africa
Prior art keywords
oxidoprogesterone
hydroy
glucocorticoids
treating excess
excess
Prior art date
Application number
ZA988674A
Other languages
English (en)
Inventor
Gerardo Burton
Carlos Pedro Lantos
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of ZA988674B publication Critical patent/ZA988674B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA988674A 1997-09-23 1998-09-22 21-Hydroy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids ZA988674B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97116526A EP0903146A1 (fr) 1997-09-23 1997-09-23 21-Hydroy-6,19oxidoprogestérone (21-OH-60P) en tant qu'antiglucocorticoide

Publications (1)

Publication Number Publication Date
ZA988674B true ZA988674B (en) 1999-06-28

Family

ID=8227390

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA988674A ZA988674B (en) 1997-09-23 1998-09-22 21-Hydroy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids

Country Status (13)

Country Link
US (1) US6303591B1 (fr)
EP (2) EP0903146A1 (fr)
AR (1) AR023008A1 (fr)
AT (1) ATE215373T1 (fr)
AU (1) AU738522B2 (fr)
CA (1) CA2303817C (fr)
DE (1) DE69804659T2 (fr)
DK (1) DK1033990T3 (fr)
ES (1) ES2172937T3 (fr)
IL (1) IL135232A (fr)
PT (1) PT1033990E (fr)
WO (1) WO1999015181A1 (fr)
ZA (1) ZA988674B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1542A (en) 1999-04-30 2006-01-31 Pfizer Prod Inc Glucocorticoid receptor modulators.
US7713989B2 (en) 2000-04-27 2010-05-11 Dow Robert L Glucocorticoid receptor modulators
US7071328B2 (en) * 2000-09-18 2006-07-04 Applied Research System Ars Holding N.V. Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21 oh-6op)
SI1330468T1 (sl) * 2000-09-18 2007-10-31 Serono Lab Ĺ˝veplovi analogi 21-hidroksi-6,19-oksido-progesterona (21oh-6op) za zdravljenje preseĺ˝ka glukokortikoidov
DE60113032T2 (de) 2000-10-30 2006-07-06 Pfizer Products Inc., Groton Glukokortikoidrezeptor-Modulatoren
US8097606B2 (en) * 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
EP1886695A1 (fr) * 2006-06-27 2008-02-13 Speedel Experimenta AG Combinaisons pharmacéutiques avec inhibiteurs de l'aldosterone synthase et antagonistes du recepteur de glucocorticoides où inhibiteurs de la synthese de cortisol où antagonistes du facteur de libération de la corticotropine
CN101528214B (zh) 2006-08-24 2013-06-05 田纳西大学研究基金会 取代的n-酰基苯胺及其使用方法
WO2011150209A1 (fr) 2010-05-26 2011-12-01 Corcept Therapeutics, Inc. Traitement de la dystrophie musculaire
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
PT2872482T (pt) 2012-07-13 2020-09-22 Oncternal Therapeutics Inc Método de tratamento de cancro de mama com modulador seletivo do recetor de andrógeno (sarm)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
AU2016226451B2 (en) 2015-03-02 2019-12-19 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonist and somatostatin analogues to treat ACTH-secreting tumors
US10610534B2 (en) 2015-03-30 2020-04-07 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
KR20180052120A (ko) 2015-08-13 2018-05-17 코어셉트 쎄라퓨틱스, 잉크. Acth-의존성 쿠싱 증후군을 감별 진단하는 방법
JP6765443B2 (ja) 2016-01-19 2020-10-07 コーセプト セラピューティクス， インコーポレイテッド 異所性クッシング症候群の鑑別診断
WO2018236749A2 (fr) 2017-06-20 2018-12-27 Corcept Therapeutics, Inc. Méthodes de traitement des tumeurs neuro-épithéliales à l'aide de modulateurs sélectifs du récepteur de glucocorticoïdes
JP2022515528A (ja) * 2018-12-28 2022-02-18 パンダ コンサルティング エルエルシー 短時間作用型選択的糖質コルチコイド受容体モジュレーター
EP4653047A3 (fr) 2019-03-18 2026-02-18 Nieman, Lynnette K. Mifepristone destinée à être utilisée pour améliorer la sensibilité à l'insuline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
AU747956B2 (en) * 1997-10-06 2002-05-30 Board Of Trustees Of The Leland Stanford Junior University Methods for treating psychosis associated with glucocorticoid related dysfunction

Also Published As

Publication number Publication date
US6303591B1 (en) 2001-10-16
ES2172937T3 (es) 2002-10-01
EP1033990B1 (fr) 2002-04-03
AR023008A1 (es) 2002-09-04
IL135232A0 (en) 2001-05-20
AU738522B2 (en) 2001-09-20
ATE215373T1 (de) 2002-04-15
PT1033990E (pt) 2002-07-31
CA2303817C (fr) 2008-04-01
AU1334199A (en) 1999-04-12
WO1999015181A1 (fr) 1999-04-01
DE69804659T2 (de) 2002-10-02
DK1033990T3 (da) 2002-07-08
CA2303817A1 (fr) 1999-04-01
IL135232A (en) 2005-05-17
EP1033990A1 (fr) 2000-09-13
EP0903146A1 (fr) 1999-03-24
DE69804659D1 (de) 2002-05-08

Similar Documents

Publication Publication Date Title
ZA988674B (en) 21-Hydroy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids
AU9035498A (en) Method for treating pain
AU7582398A (en) Composition for treating skin conditions
IL127455A (en) Progesterone for treating or reducing ischemia
ZA976559B (en) Method for activation of bleaches.
GB9821217D0 (en) Treatment for substrates
GB9620638D0 (en) Setting composition for well operations
ZA986363B (en) Novel method of treatment.
ZA985237B (en) Novel method of treatment.
ZA986364B (en) Novel method of treatment.
AU7107998A (en) Method for treating schizophrenia
ZA986365B (en) Novel method of treatment.
AU9034798A (en) Method for treating pain
AU6760298A (en) Method for treating hypertension
PL341667A1 (en) Method of treating cooped
EP0682034A3 (fr) Procédé de préparation de cyanoalkylorganooxysilanes de cyanoalkylchlorosilanes.
PL340430A1 (en) Combination for treating aids
AU6966998A (en) Composition for treating pain
PL334803A1 (en) Derivatives of imino-aza-antracyclinone for treating amyloidosis
GB9714841D0 (en) Treatment method
PL320799A1 (en) 14alpha, 17alpha-c2-bridged derivatives of 19-norprogesterone
AU7247898A (en) Composition for treating pain
AU7936898A (en) Vectors for treating cancer
AU6641498A (en) Process for treating wastewater
GB2331514B (en) Effluent treatment